Evaluation of the Efficacy of 0.8% Hyaluronic Acid Gel
Status:
Completed
Trial end date:
2017-10-02
Target enrollment:
Participant gender:
Summary
assess the clinical and laboratory effects of the local and sub gingival application of a
0.8% hyaluronic acid gel (GENGIGEL®) as an adjunct to scaling and root planning (SRP) in
chronic moderate to severe periodontitis patients as indicated by expression of Human Beta
Definsin-2 (HBD2) in gingival crevicular fluid (GCF).